| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.053 | 0.2 |
| mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | CHEMBL374350 | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | 0.053 | 0.3 |
| mRNA | Pazopanib | GDSC1000 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.3 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.3 |